Table 3.
Univariate and multivariate analysis of clinicopathologic variables in relation to liver metastasis and overall survival after curative operation.
Liver Metastasis |
Overall Survival |
|||||||
---|---|---|---|---|---|---|---|---|
Univariate analysis | Multivariate analysis |
Univariateanalysis | Multivariate analysis |
|||||
Parameter | N | P value | HR(95% CI) | P value | P value | HR(95% CI) | P value | |
Gender | Male | 98 | 0.92 | 0.59 | ||||
Female | 57 | |||||||
Age(years) | <65 | 85 | 0.43 | 0.11 | ||||
≥65 | 70 | |||||||
Albumin(g/dL) | <3.5 | 18 | 0.39 | 0.89 | ||||
≥3.5 | 137 | |||||||
CEA(ng/mL) | <5 | 114 | 0.12 | 0.00 | 1 | 0.04 | ||
≥5 | 41 | 1.63(1.04-2.59) | ||||||
CA125(U/mL) | <35 | 124 | 0.91 | 0.05 | 1 | 0.08 | ||
≥35 | 31 | 1.619(0.95-2.74) | ||||||
CA19-9(U/mL) | <39 | 32 | 0.11 | 0.01 | 1 | 0.56 | ||
≥39 | 123 | 1.15(0.71-1.87) | ||||||
ABO | A | 55 | 0.13 | 0.94 | ||||
AB | 19 | |||||||
B | 48 | |||||||
O | 33 | |||||||
Location | Uncinate process | 48 | 0.80 | 0.43 | ||||
Head | 71 | |||||||
Body and tail | 36 | |||||||
Differentiation | Poor | 75 | 0.20 | 0.16 | ||||
Well to moderate | 80 | |||||||
Diameter(cm) | <3.5 | 68 | 0.20 | 0.01 | 1 | 0.04 | ||
≥3.5 | 87 | 1.50 (1.02-2.22) | ||||||
T staging | 1-2 | 54 | 0.01 | 1 | 0.03 | <0.01 | 1 | 0.04 |
3-4 | 101 | 1.67(1.06-2.62) | 1.55(1.03-2.33) | |||||
LN metastasis | Negative | 69 | 0.15 | <0.01 | 1 | <0.01 | ||
Positive | 86 | 1.95(1.32-2.87) | ||||||
AJCC | <IIb | 67 | 0.08 | 1 | 0.33 | <0.01 | 1 | 0.88 |
≥IIb | 88 | 1.234(0.81-1.89) | 1.12(0.26-4.74) | |||||
Stromal TILs | Positive | 100 | <0.01 | 1 | <0.01 | <0.01 | 1 | <0.01 |
Negative | 55 | 2.80(1.75-4.48) | 2.70(1.80-4.06) |
Abbreviations: TILs = tumor-infiltrating lymphocytes; LN = lymph node; HR = hazard ratio; CI = confidence interval.